#AHA22
Virtual Experience Access
Sessions Posters
Late-Breaking Science
Daily Coverage
Industry Highlights
Featured Exhibitors
Program
Previews
AHA22
Sharing the good
AHA CEO Nancy Brown delivers impressive updates
AHA22
Overcoming adversity and related poor health from birth to adulthood
AHA22
Moving past the status quo to overcome CVD and health disparities
AHA22
Thought leaders to inspire at Main Events
AHA22
Download the 2022 On-Site Meeting Guide
AHA22
#AHA 22 Closing Session: That’s a wrap
Artificial intelligence, trials and studies among the highlights of this year’s event.
AHA22
Congratulations to the winners of the Wellness Challenge and Scavenger Hunt
Sponsored
MiCare Path joins the AHA CHTI and will integrate AHA science-based
CarePlans into its platform
AHA22
Special Recognition to the Hinsdale Humane Society
AHA22
Trial results shed light on tool for assessing VTE risk, routine anticoagulation for non-hospitalized COVID patients, and clinical outcomes of open vs. endovascular surgery for advanced PAD
AHA22
Bivalirudin superior to unfractionated heparin in primary PCI following STEMI
Late-Breaking Science
Overcoming health disparities, health care advocates and mindfulness can better manage BP and CVD
AHA22
Medtech is getting smarter — and so is patient care
Four new innovations seek to redefine how cardiovascular care is done.
AHA22
New digital hub offers professional education to complement lifelong learning
AHA22
Trial results report on benefits of radial artery for CABG, use of prophylactic methylprednisolone and ECMO for patients in cardiogenic shock
AHA22
And the Health Tech Competition winner is…
A new software platform that transforms clinical content into instantly available information takes the prize.
AHA22
Read all about it
AHA22
Science, medicine must be a ‘relentless force’ in fighting misinformation
AHA22
Paul Dudley White International Lecture explores link between poverty, COVID-19 and CVD risk
AHA22
The AHA selects seven Distinguished Scientists
Daily Coverage
Advances may lead to more powerful therapies for arrhythmia
AHA22
There’s no such thing as a small study in improving CVD treatment
AHA22
New therapies for cardiovascular disease reach clinical trial stage
AHA22
Transitioning from fellow to faculty can be tricky
AHA22
One Brave Idea aims to change the future of heart disease
AHA22
Stay connected
AHA22
Harriette Van Spall and Erica Gunderson honored with the Dr. Nanette K. Wenger Research Goes Red® Award